Clinical Trials on Transitional Cell Carcinoma in New Zealand
Total 7813 results
-
Memorial Sloan Kettering Cancer CenterNovartisCompletedMetastatic Transitional Cell Carcinoma of the UrotheliumUnited States
-
Trans Tasman Radiation Oncology GroupNational Health and Medical Research Council, AustraliaCompletedTransitional Cell Carcinoma of Urinary BladderAustralia, New Zealand
-
Yale UniversityWithdrawnTransitional Cell CarcinomaUnited States
-
Memorial Sloan Kettering Cancer CenterNovartis PharmaceuticalsCompletedBladder Cancer | Metastatic Transitional Cell CarcinomaUnited States
-
UroGen Pharma Ltd.CompletedCarcinoma, Transitional Cell | Transitional Cell Carcinoma of Renal PelvisUnited States, Israel
-
Ludwig Institute for Cancer ResearchNational Cancer Institute (NCI)CompletedTransitional Cell CarcinomaUnited States
-
Endo PharmaceuticalsTerminatedCarcinoma in Situ | Transitional Cell Carcinoma | Non-muscle Invasive Bladder CancerUnited States
-
Memorial Sloan Kettering Cancer CenterNational Cancer Institute (NCI)CompletedBladder Cancer | Transitional Cell Cancer of the Renal Pelvis and UreterUnited States
-
Tulane University Health Sciences CenterCompletedBladder Cancer | Transitional Cell Cancer of the Renal Pelvis and UreterUnited States
-
Auckland District Health BoardNovartis; University of Auckland, New Zealand; IGENZ, Ltd., AucklandUnknownClear Cell Renal Cell CarcinomaNew Zealand
-
Memorial Sloan Kettering Cancer CenterNational Cancer Institute (NCI)CompletedBladder Cancer | Transitional Cell Cancer of the Renal Pelvis and UreterUnited States
-
Memorial Sloan Kettering Cancer CenterNational Cancer Institute (NCI)CompletedBladder Cancer | Transitional Cell Cancer of the Renal Pelvis and UreterUnited States
-
All India Institute of Medical Sciences, New DelhiCompletedRenal Cell Carcinoma | Transitional Cell Carcinoma | AML | Renal CystsIndia
-
Weill Medical College of Cornell UniversityNeoTX Therapeutics Ltd.WithdrawnUrothelial CarcinomaUnited States
-
Memorial Sloan Kettering Cancer CenterMayo Clinic; Hartford HospitalActive, not recruitingUrothelial CarcinomaUnited States
-
Memorial Sloan Kettering Cancer CenterAstellas Pharma US, Inc.RecruitingUrothelial CarcinomaUnited States
-
Cadila PharnmaceuticalsCompleted
-
Memorial Sloan Kettering Cancer CenterCompletedTransitional Cell Carcinoma | Bladder CancerUnited States
-
Roswell Park Cancer InstituteNational Cancer Institute (NCI)TerminatedMucositis | Xerostomia | Radiation Toxicity | Stage III Squamous Cell Carcinoma of the Hypopharynx | Stage III Squamous Cell Carcinoma of the Larynx | Stage III Squamous Cell Carcinoma of the Lip and Oral Cavity | Stage III Squamous Cell Carcinoma of the Nasopharynx | Stage III Squamous Cell Carcinoma... and other conditionsUnited States, New Zealand
-
Gynecologic Oncology GroupNational Cancer Institute (NCI)CompletedRecurrent Uterine Corpus Carcinoma | Endometrial Clear Cell Adenocarcinoma | Endometrial Serous Adenocarcinoma | Endometrial Undifferentiated Carcinoma | Endometrial Adenocarcinoma | Endometrial Transitional Cell Carcinoma | Endometrial Mucinous Adenocarcinoma | Endometrial Mixed Adenocarcinoma | Endometrial...United States
-
Cadila PharnmaceuticalsCompleted
-
Memorial Sloan Kettering Cancer CenterNational Cancer Institute (NCI); PfizerCompletedBladder Cancer | Transitional Cell Cancer of the Renal Pelvis and Ureter | Urethral CancerUnited States
-
Memorial Sloan Kettering Cancer CenterActive, not recruitingUpper Tract Urothelial CarcinomaUnited States
-
Roswell Park Cancer InstituteJohns Hopkins University; National Cancer Institute (NCI)TerminatedRecurrent Bladder Cancer | Transitional Cell Carcinoma of the Bladder | Stage 0 Bladder Cancer | Stage I Bladder Cancer | Stage II Bladder CancerUnited States
-
Arjun Balar, MDHoosier Cancer Research Network; Roche-GenentechTerminatedUrothelial CarcinomaUnited States
-
Genentech, Inc.TerminatedUrothelial CarcinomaKorea, Republic of, United States, Canada, United Kingdom, Belgium
-
Genentech, Inc.Approved for marketing
-
Hoosier Cancer Research NetworkBristol-Myers SquibbCompletedUrothelial CarcinomaUnited States
-
Medical Research CouncilCompletedBladder Cancer | Transitional Cell Cancer of the Renal Pelvis and Ureter | Urethral CancerCanada, United Kingdom, Norway, New Zealand, Netherlands, South Africa, Brazil, Finland
-
Gynecologic Oncology GroupNational Cancer Institute (NCI)CompletedRecurrent Uterine Corpus Carcinoma | Endometrial Clear Cell Adenocarcinoma | Endometrial Serous Adenocarcinoma | Endometrial Undifferentiated Carcinoma | Endometrial Adenocarcinoma | Endometrial Transitional Cell Carcinoma | Endometrial Mucinous Adenocarcinoma | Endometrial Mixed Adenocarcinoma | Endometrial...United States
-
AmgenUnknownBladder Cancer | Transitional Cell Cancer of the Renal Pelvis and UreterUnited States
-
Five Prime Therapeutics, Inc.CompletedGastric Cancer | Advanced Solid Tumors | Transitional Cell Carcinoma of the BladderKorea, Republic of, United States, Taiwan
-
Matthew GalskyAstraZenecaActive, not recruitingUrothelial CarcinomaUnited States
-
Matthew GalskyNovartis Pharmaceuticals; Hoosier Cancer Research NetworkTerminatedTransitional Cell Carcinoma | Urothelial Carcinoma | Bladder CarcinomaUnited States
-
Mirati Therapeutics Inc.CompletedUrothelial CarcinomaUnited States
-
Nabil AdraGenentech, Inc.; Indiana University School of MedicineTerminated
-
Memorial Sloan Kettering Cancer CenterMerck Sharp & Dohme LLC; Astellas Pharma US, Inc.; Seagen Inc.RecruitingUrothelial CarcinomaUnited States
-
Antisoma ResearchCompletedMetastatic Renal Cell Carcinoma | Metastatic Malignant MelanomaUnited Kingdom, New Zealand
-
MedPacto, Inc.AstraZenecaNot yet recruitingUrothelial Carcinoma Recurrent | Advanced Urothelial CarcinomaUnited States
-
Memorial Sloan Kettering Cancer CenterGlaxoSmithKlineTerminated
-
Genta IncorporatedUnknownCarcinoma, Transitional CellUnited States, Italy
-
Memorial Sloan Kettering Cancer CenterUniversity of Chicago; Genentech, Inc.; Ohio State University; TargosActive, not recruitingUrothelial Carcinoma | Locally Advanced | UnresectableUnited States
-
Vyriad, Inc.Mayo ClinicCompletedUrothelial CarcinomaUnited States
-
Hoffmann-La RocheTerminatedCarcinoma, Transitional CellUnited States, Korea, Republic of, France, United Kingdom, Belgium, Canada, China, Greece, Spain, Turkey, Japan, Czechia, Israel, Italy, Russian Federation, Poland, Switzerland, Australia, Germany, Netherlands, Taiwan, Ukraine, Serbia, Finla...
-
Gynecologic Oncology GroupNational Cancer Institute (NCI)CompletedRecurrent Uterine Corpus Carcinoma | Endometrial Clear Cell Adenocarcinoma | Endometrial Serous Adenocarcinoma | Endometrial Undifferentiated Carcinoma | Endometrial Adenocarcinoma | Endometrial Transitional Cell Carcinoma | Endometrial Mucinous Adenocarcinoma | Endometrial Squamous Cell Carcinoma | Malignant Uterine Corpus Mixed Epithelial and Mesenchymal NeoplasmUnited States
-
AstraZenecaCompletedUrothelial CarcinomaUnited States
-
Memorial Sloan Kettering Cancer CenterBayerTerminatedBladder Cancer | URINARY BLADDERUnited States
-
Acrotech Biopharma Inc.CompletedCarcinoma, Transitional Cell | Bladder Cancer | Bladder NeoplasmSpain, France, Belgium, United States, Argentina, Croatia
-
Novartis PharmaceuticalsCompletedUrothelial CancerUnited States, Spain, Taiwan, Germany, Canada, United Kingdom, Italy, Austria